McKesson Corporation vs SoFi Technologies Inc — how do they compare? McKesson Corporation trades at $937.1 (market cap $108.46B), while SoFi Technologies Inc trades at $15.75 (market cap $20.16B). The key difference: McKesson Corporation is far larger — about 5.4× SoFi Technologies Inc's market cap, and McKesson Corporation pays a 0.4% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and SoFi Technologies Inc for 60 Days on average.
| MCK | SOFI | |
|---|---|---|
Market Cap | $108.46B | $20.16B |
Volume | 712,607 | 49,646,331 |
Sector | Health | Financials |
52-Week High | $995.69 | $32.21 |
52-Week Low | $725.17 | $15.15 |
Typical Hold Time | 74 Days | 60 Days |
Enterprise Value | $115.00B | $20.30B |
Dividend Yield | 0.4% | — |
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $938.84, up 3.13% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.
The outlook is positive with 81% analyst buy ratings and a $956.43 consensus price target. Key risks include margin pressure from drug pricing policies and high current liabilities of $61.60B. The stock's valuation at 24.95x P/E appears reasonable given earnings growth projections, but investors should monitor debt levels and regulatory developments in healthcare distribution.
SoFi Technologies trades at $15.80, up 0.89% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth from $2.6B in 2024 to $3.6B in 2025, though net income dipped to $481M. Analyst consensus is mixed with 37% buy ratings but a $21.58 price target suggesting 37% upside. Recent news highlights stablecoin initiatives and record loan originations amid sector volatility.
SoFi presents a growth story with expanding financial services but faces execution risks in a competitive fintech landscape. The stock's current valuation at 31.86 P/E reflects optimism about future profitability, though negative operating cash flows and rising yields create headwinds. Upside depends on sustained loan growth and successful monetization of new products like SoFiUSD.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →